Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
262 participants
OBSERVATIONAL
2020-04-01
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Traditionally, underlying lung disease or age are known risk factors for non-trauma related barotrauma. However, in patients with novel coronavirus disease (COVID-19), the incidence of this complication is more common than in non-infected patients, as recently reported. Since little is known regarding which are the main risk factors for these events to develop, most pathophysiological mechanisms remain unexplained.
The aim of this study was to determine the risk factors for developing barotrauma in patients under MV with COVID-19 associated Acute Respiratory Distress Syndrome (ARDS). Secondary objectives were to determine the incidence of barotrauma and its association with mortality.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Barotrauma in Adults With Critical COVID-19
NCT05877443
Paradoxical Response to Chest Wall Loading in Mechanically Ventilated Patients
NCT06093958
Extrapulmonary Lung Protection Strategy for Patients With Mechanical Ventilation
NCT03947476
Risk Factors for Prolonged Mechanical Ventilation in Elevated Mean Airway Pressure
NCT05902403
Predictors of Non-invasive Respiratory Support Failure in COVID-19 Pneumonia
NCT05094661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Barotrauma/cases
Cases were defined as patients with barotrauma consulted with the Surgery Department
No intervention
No intervention
No braotruma/Controls
Controls were selected from a random sample of the COVID-19-ARDS cohort.
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Horacio Marquez-Gonzalez
UNKNOWN
Carlos Torruco-Sotelo
UNKNOWN
Sebastian Rodriguez-Llamazares
UNKNOWN
Hospital General Ajusco Medio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karla Verónica Chavez-Tostado
Head of Surgery Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital General Ajusco Medio
Mexico City, , Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HGAM01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.